Kurt Von Emster, Director at CRISPR Therapeutics AG (CRSP), sold 75,943 shares at $33.17 ($2.3M) on 2018-12-17, disclosed to the SEC on 2018-12-19.
Open-market sale of $2.3M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.17 | 3,009 | $100K | 4.4% |
| 2 | $33.17 | 3,009 | $100K | 4.4% |
| 3 | $29.70 | 69,925 | $2.1M | 91.2% |
| Total | $29.97 avg | 75,943 | $2.3M | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |